We should applaud drug companies for developing COVID-19 vaccines in record time, but let’s not be under any illusion about the profits that are motivating them.
The pandemic has made politics raw because the impact of political decisions is felt immediately in the daily lives of citizens — and there are winners and losers resulting from those decisions.
In this video interview, Dr Doyin Odubanjo, Executive Secretary of the Nigerian Academy of Science and a public health expert, talks about keeping safe while celebrating Christmas during COVID-19.
The pandemic is placing strain not just on doctors and nurses but the medical laboratory professionals who conduct the billions of medical tests behind the scenes.
Addiction remains shrouded in stigma, while the system through which we provide addiction treatment in Australia is fragmented and failing. There’s no better time to address these issues.
With the pressures of the holidays, rising COVID-19 rates and social isolation, people can easily fall into addictive-like behaviours. Here are some ways to challenge ourselves and family.
Over nine months into COVID-19 outbreak in Nigeria, there are concerns about how well the country has managed the disease pandemic and how this might affect its handling of other diseases.
Desi Kotis, University of California, San Francisco
Health systems around the US are on the cusp of receiving COVID-19 vaccines. At the end of this months-long effort are the nitty-gritty details of how health care providers are giving people the vaccine.
The absence of effective government policy doesn’t make citizens free. It takes away their power, leaving them less able to act to address their needs. That’s especially clear during the pandemic.
The pandemic, along with other recent trends such as the shift towards clean energy, have placed us at a crossroad: the choices we make today can change the course of global emissions.
Reports of two UK health workers having allergic reactions after receiving Pfizer’s COVID vaccine have led to safety warnings for others at risk of anaphylaxis.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand